These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 6867237)

  • 21. What may be gained from neuropsychological investigations of tardive dyskinesia?
    Cohen H; Cohen D
    Brain Cogn; 1993 Sep; 23(1):1-7. PubMed ID: 8105818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dyskinesia: recognition, management, and prevention.
    Crews EL
    Ala J Med Sci; 1980 Apr; 17(2):165-8. PubMed ID: 7416430
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tardive dyskinesia. AIMS (Abnormal Involuntary Movement Scale) as a diagnostic and research tool].
    Burti L; Parolin A; Zanotelli R
    Minerva Med; 1981 Oct; 72(42):2829-36. PubMed ID: 7312199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent parkinsonism and tardive dyskinesia induced by clebopride.
    Jiménez-Jiménez FJ; Cabrera-Valdivia F; Ayuso-Peralta L; Tejeiro J; Vaquero A; García-Albea E
    Mov Disord; 1993 Apr; 8(2):246-7. PubMed ID: 8474508
    [No Abstract]   [Full Text] [Related]  

  • 26. Algorithms for neuroleptic-associated tardive movement disorders.
    Akiyama K
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S23-9. PubMed ID: 10560894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug therapy in tardive dyskinesia].
    Neumann NU
    Fortschr Med; 1980 Nov; 98(42):1636-40. PubMed ID: 7461556
    [No Abstract]   [Full Text] [Related]  

  • 28. Tardive jaw tremor.
    Ebersbach G; Tracik F; Wissel J; Poewe W
    Mov Disord; 1997 May; 12(3):460-2. PubMed ID: 9159750
    [No Abstract]   [Full Text] [Related]  

  • 29. Tardive dyskinesia: a review and current treatment options.
    Najib J
    Am J Ther; 1999 Jan; 6(1):51-60. PubMed ID: 10423647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing the risk of tardive dyskinesia.
    Glazer WM; Saltz BL
    Behav Healthc; 2006 Dec; 26(12):27-32. PubMed ID: 17233380
    [No Abstract]   [Full Text] [Related]  

  • 31. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central determinants of attention and mood disorder in tardive dyskinesia ("tardive dysmentia").
    Myslobodsky MS
    Brain Cogn; 1993 Sep; 23(1):88-101. PubMed ID: 8217124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tardive dyskinesia monitoring policy for applied facilities.
    Kalachnik JE; Larum JG; Swanson A
    Psychopharmacol Bull; 1983; 19(2):277-82. PubMed ID: 6867237
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.